Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 639

1.

Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.

Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LA.

Ann Surg Oncol. 2006 Jan;13(1):36-44.

2.

Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.

Breast J. 2004 Mar-Apr;10(2):101-5.

PMID:
15009035
3.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
4.

[Validation study of the sentinel lymph node (SLN) method in invasive breast carcinoma. Personal data and review of the literature].

Langer I, Zuber M, Köchli OR, Kocher T, Müller-Brand J, Torhorst J, Harder F.

Swiss Surg. 2000;6(3):128-36. Review. German.

PMID:
10894014
5.

Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.

de Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T.

Eur J Surg Oncol. 2003 Apr;29(3):216-20.

PMID:
12657229
6.

Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.

Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A.

Eur J Surg Oncol. 2006 Feb;32(1):29-33.

PMID:
16269227
7.

Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.

Travagli JP, Atallah D, Mathieu MC, Rochard F, Camatte S, Lumbroso J, Garbay JR, Rouzier R.

Eur J Surg Oncol. 2003 May;29(4):403-6.

PMID:
12711299
8.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group..

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
9.

Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.

Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG.

J Clin Oncol. 2008 May 1;26(13):2093-8. doi: 10.1200/JCO.2007.11.9479.

PMID:
18445838
10.

Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.

Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N.

Int J Surg Pathol. 2010 Feb;18(1):36-41. doi: 10.1177/1066896909332113.

PMID:
19448065
11.

Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.

Changsri C, Prakash S, Sandweiss L, Bose S.

Breast J. 2004 Sep-Oct;10(5):392-7.

PMID:
15327491
12.
13.

Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.

Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI.

Ann Surg Oncol. 2003 Apr;10(3):248-54.

PMID:
12679309
14.

Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.

Katz A, Niemierko A, Gage I, Evans S, Shaffer M, Smith FP, Taghian A, Magnant C.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):40-4.

PMID:
16488555
15.

Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F.

Arch Surg. 2004 Jun;139(6):648-51.

PMID:
15197092
16.

A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.

Cho J, Han W, Lee JW, Ko E, Kang SY, Jung SY, Kim EK, Moon WK, Cho N, Park IA, Chung JK, Hwang KT, Kim SW, Noh DY.

Ann Surg Oncol. 2008 Aug;15(8):2278-86. doi: 10.1245/s10434-008-9993-z.

PMID:
18528729
17.

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9.

PMID:
19760047
19.

Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.

Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.

Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.

PMID:
20566977
20.

[Is axillary lymph node dissection always necessary in breast cancer patients with a positive sentinel node?].

Coutant C, Morel O, Antoine M, Uzan S, Barranger E.

J Chir (Paris). 2007 Nov-Dec;144(6):492-501. Review. French.

PMID:
18235360

Supplemental Content

Support Center